CNS
Aiming for the social reintegration of patients with psychiatric and neurological disordersDiseases of the central nervous system are also known as psychiatric and neurological disorders. Since the causes of and fundamental treatments for these conditions have not been fully understood, it is a challenge to create new drugs in this area, even for companies that have produced innovative medicines in the past.
In order to take on the challenge of creating new drugs, a company needs not only enthusiasm, passion, and curiosity, but also new ideas discovered by taking untrodden paths. As an industry pioneer with a venture spirit, Medicamen aims to further assist patients and their families by working with global partners in the field of central nervous system disorder.
Together with them Medicamen is developing innovative drugs for psychiatric and neurological disorders, and is taking on the challenge of introducing new technologies and new dosage formats to ensure reliable medication delivery.
For more information on products, please click on the link below:
Central Nervous System diseases
- Schizophrenia
- Epilepsy
- Bipolar disorder
- Parkinson's disease
- Depression
- Restless legs syndrome
- Autism spectrum disorder for children
